HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$33.09
+0.62 (+1.91%)
Performance
1D
-0.06%
1W
-12.71%
1M
-16.44%
3M
-15.15%
6M
+9.64%
1Y
+5.28%
YTD
-11.48%
Open$32.69
Previous Close$32.47
Day High$33.39
Day Low$32.27
52W High$43.49
52W Low$25.90
Volume—
Avg Volume1.29M
Market Cap1.93B
P/E Ratio10.62
EPS$3.09
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$39.36
Below
SMA 200
$34.66
Below
RSI (14)
33.6
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+182.6% upside
Current
$33.09
$33.09
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 863.36M | 687.17M | 502.35M |
| Net Income | 157.75M | 113.00M | 88.37M |
| Profit Margin | 18.3% | 17.4% | 17.6% |
| EBITDA | 230.95M | 174.63M | 150.20M |
| Free Cash Flow | — | — | 92.06M |
| Rev Growth | +25.6% | +25.6% | +14.6% |
| Debt/Equity | 0.19 | 0.19 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |